{"name":"Institut de Recherches Internationales Servier (I.R.I.S.)","slug":"institut-de-recherches-internationales-servier-i-r-i-s","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiX0FVX3lxTFB3SWp6SnNJYV91aG42anhEX3lVMWVYQWRTbnY3ejZJd1IwRU5XSngycFEzNkdNSXF6a2tZazItUG12akF1VWl0VjRqM2N1d1FEQllESFR1YnhWdUZSdHNz?oc=5","date":"2025-01-06","type":"trial","source":"nature.com","summary":"MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial - nature.com","headline":"MAT2A inhibitor AG-270/S095033 in patients with advanced malignancies: a phase I trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTFBWbkxzQVI0RW5OdUsweHAtS1IyMktsVjJrSWNFWWN2aUF6dlliZ1JtRExPanJWWXJzVVV1aXZOOU9IbXNJM1BuSENMLU1paTFvNjV4WG4wWndoY2U4WDJ3ZFVtRm5FemZnS3RKRVA5Q0hnR1pUNzdmbDN4X0h5RlE?oc=5","date":"2024-11-02","type":"pipeline","source":"Site Selection Magazine","summary":"French Pharma Giant Launches Research Institute - Site Selection Magazine","headline":"French Pharma Giant Launches Research Institute","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRTk1WUd1djVnTS1LdDh4dHVxamhlNG1XamtSODhVQjlkYUNUM09peWxaSTcyTTU3X1ZSU0NIX0ZRWGpjVDdoeTRBcThXVzU0enNVSzZ0UGNnYmd6eXZDdmdaMTluaW9PV3dHNEw4aW1YM3FYU1dfVm51S3JiN282b3h3V1RLdHJVS1lSYW1CWHVDQmNFSGx1MDdIdFVIcU5QVHM1bzNBMFRLOERKUEFZQ1RwRlFOS2IzRWJj?oc=5","date":"2022-10-06","type":"pipeline","source":"Servier","summary":"The Research and Development Institute in Paris-Saclay - Servier","headline":"The Research and Development Institute in Paris-Saclay","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMihgFBVV95cUxNWEdiVTNobmNpZmNGUFowMHFJOWVnNHU1b196MDdsRjhfVkx1VDhDdVVrUTFDRjBSR0ZnMHQxU2toWEg0V194M3V4eGw3Nl9sRjBpcnI5RGhnQjNNNU9wT2NRLWptT3JOMVFQM3BSU3JkcWtVdmJUV0htSEZIaHhTRnhRUmtWZw?oc=5","date":"2021-04-01","type":"pipeline","source":"CRISPR Medicine News","summary":"CMN Markets April 2021 (open access edition) - CRISPR Medicine News","headline":"CMN Markets April 2021 (open access edition)","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":3,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}